Vir Biotechnology Shares Move Lower; Co, WuXi Biologics Terminate A Greater China Collaboration Agreement For Antibodies Including VIR-7831
As previously disclosed, Vir Biotechnology, Inc. (the “Company”) and WuXi Biologics (Hong Kong) Limited (“WuXi Bio”) entered into a Development and Manufacturing Collaboration Agreement dated